These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6139114)

  • 21. [Methyldopa: study of the antihypertensive and renin-reducing effects at rest and after exercise].
    Sbissa AS; Sbissa LA; Thiesen AL; Zunino JN
    Arq Bras Cardiol; 1981 Sep; 37(3):213-7. PubMed ID: 7052027
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hypotensive effect of metoprolol].
    Cybulska I; Brym E; Czerniewska E; Sznajderman M
    Pol Tyg Lek; 1982 Jun; 37(18):535-7. PubMed ID: 6757898
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of hypertension with tenormin 100 (atenolol). A general practice study (author's transl)].
    Hiemstra S; Ziegler E
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1777-80. PubMed ID: 6779149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antihypertensive effects of ecarazine hydrochloride in essential hypertension and its action on the renin-aldosterone system].
    Hata S; Yoshioka M; Kunida H
    Horumon To Rinsho; 1976 Sep; 24(9):919-34. PubMed ID: 795573
    [No Abstract]   [Full Text] [Related]  

  • 26. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
    Verho M; Kirsten R; Bückert C
    Pharmatherapeutica; 1984; 3(9):595-606. PubMed ID: 6374680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nadolol, a long-term acting beta blocking agent, in the treatment of essential arterial hypertension].
    Semplicini A; Pessina AC; Rossi GP; Tagliafierro R; Lusiani L; Castellani V; Bedogni F; Mazzucato A; Ronsisvalle G
    Cardiologia; 1982 Sep; 27(9):853-64. PubMed ID: 6765278
    [No Abstract]   [Full Text] [Related]  

  • 29. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive efficacy of FK906, a novel human renin inhibitor.
    Ogihara T; Nagano M; Higaki J; Higashimori K; Masuo K; Mikami H
    Clin Ther; 1993; 15(3):539-48. PubMed ID: 8364945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Daily profile of pulse rate and blood pressure. Use of betablocker-diuretic combination (author's transl)].
    Kirchhoff HW
    MMW Munch Med Wochenschr; 1981 Jan; 123(4):124-8. PubMed ID: 6783878
    [No Abstract]   [Full Text] [Related]  

  • 32. Prorenin and beta-blockade in hypertension.
    McKenna F; Davison AM
    Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive and humoral effects of verapamil and lacidipine in combination in hypertensive patients.
    Comerio G; Cuspidi C; Bocciolone M; Lonati L; Sampieri L; Boselli L; Leonetti G; Zanchetti A
    J Hypertens Suppl; 1993 Dec; 11(5):S336-7. PubMed ID: 8158411
    [No Abstract]   [Full Text] [Related]  

  • 34. Antihypertensive effect of nicardipine hydrochloride in essential hypertension.
    Takabatake T; Ohta H; Yamamoto Y; Maekawa M; Arai S; Hattori N; Nomura G
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):346-52. PubMed ID: 6749700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of adrenergic blockaders in hypertension].
    Zonis BIa; Pashkova TL
    Sov Med; 1986; (2):89-91. PubMed ID: 3518078
    [No Abstract]   [Full Text] [Related]  

  • 37. The influence of serum aldosterone and the aldosterone-renin ratio on pulse wave velocity in hypertensive patients.
    Park S; Kim JB; Shim CY; Ko YG; Choi D; Jang Y; Chung N
    J Hypertens; 2007 Jun; 25(6):1279-83. PubMed ID: 17563542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C; Mantellini R; Fanti P; Sciarra F
    Minerva Med; 1983 Apr; 74(14-15):791-7. PubMed ID: 6339999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renin-angiotensin-aldosterone system in diabetes, arterial hypertension and orthostatic hypotension].
    Khristov V; Maleeva A; Turkolev N
    Vutr Boles; 1980; 19(4):28-31. PubMed ID: 6998133
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
    Noshiro T; Miura Y; Yoshinaga K; Iimura O; Inagaki Y; Saruta T; Ishii M; Yamazaki N; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):240-5. PubMed ID: 7620695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.